MRVI Maravai unit TriLink wins China patent for CleanCap mRNA capping technology Maravai LifeSciences’ TriLink unit secured a newly issued C
MRVI Maravai unit TriLink wins China patent for CleanCap mRNA capping technology Maravai LifeSciences’ TriLink unit secured a newly issued China patent for CleanCap mRNA capping technology, strengthening IP Protection in a key market. Patent ZL 2025 1 1246578.X covers Co-transcriptional RNA synthesis methods using trimer or tetramer capping structures across the CleanCap analog suite. Coverage includes the latest M6 analog, extending Protection for technology used in commercial COVID-19 mRNA and saRNA vaccines.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.